Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 127,064 shares at $18.29 ($2.3M) on 2016-05-05, disclosed to the SEC on 2016-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.29 | 61,282 | $1.1M | 48.3% |
| 2 | $18.29 | 61,282 | $1.1M | 48.3% |
| 3 | $17.15 | 4,500 | $77K | 3.3% |
| Total | $18.25 avg | 127,064 | $2.3M | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |